Boots (India) Pharma Private Limited
About Boots (India) Pharma Private Limited
Data last updated:
Boots (India) Pharma Private Limited was a private limited company based in Delhi, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 09 May 2008.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC177907.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹80,000. It was led by directors Amit Singla and Arun Gupta.
Its last annual general meeting (AGM) was held on 14 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at House No. 220 Pkt – 8 Sector 22 Rohini Near Bajaj Property, Delhi, India – 110086.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.97 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹6.48 Lakh (net margin 65%) and EBITDA of ₹8.66 Lakh (EBITDA margin 86.8%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 3% over five years.
Company details
Contact details
Boots (India) Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 220 Pkt – 8 Sector 22 Rohini Near Bajaj Property, Delhi, India – 110086
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Boots (India) Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Boots (India) Pharma Private Limited
FY 2024 filings availableBoots (India) Pharma Private Limited reported revenue of ₹9.97 Lakh (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 7% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 86.8% | ||||
| Net Profit Margin | 65% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Boots (India) Pharma Private Limited, buy the company report.
Board of directors of Boots (India) Pharma Private Limited
Boots (India) Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Singla | Director | 30 May 2019 | 7 Years 5 Months | As last reported |
| Arun Gupta | Director | 09 May 2008 | 18 Years 5 Months | As last reported |
Auditor
Boots (India) Pharma Private Limited is audited by J D A & COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J D A & COMPANY | FY 2017 | 015377N |
Shareholding
The shareholding of Boots (India) Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Boots (India) Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Boots (India) Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Boots (India) Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Boots (India) Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Boots (India) Pharma Private Limited has 4 board changes on record since 2008: 2 appointments and 2 cessations. The latest: Amit Singla ceased to be Additional Director on 27 Sep 2019.
Frequently asked questions
Boots (India) Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Boots (India) Pharma was a private limited company based in Delhi, India. The company worked in business and IT consulting, within the business outsourcing industry. It was incorporated on 09 May 2008 and is registered under CIN U24232DL2008PTC177907. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Boots (India) Pharma was incorporated on 09 May 2008. It is registered with the Registrar of Companies, Delhi.
Boots (India) Pharma had 2 directors:
- Amit Singla - Director
- Arun Gupta - Director
The CIN (Corporate Identification Number) of Boots (India) Pharma is U24232DL2008PTC177907. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Boots (India) Pharma is at House No. 220 Pkt – 8 Sector 22 Rohini Near Bajaj Property, Delhi, India – 110086.
The latest financial statements of Boots (India) Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 14 September 2024. Year-wise statements from 2015 are in the company report.
Boots (India) Pharma operated in the business outsourcing industry, in the business and IT consulting segment.
Amit Singla ceased to be Additional Director on 27 Sep 2019. Amit Singla was appointed as Director on 30 May 2019. Inder Singh Gupta ceased to be Director on 30 May 2019. Boots (India) Pharma has 4 board changes on record in total.
The compliance status of Boots (India) Pharma is compliant as of 08 August 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
